Manufacturer:
Celltrion
Route of Administration:
Subcutaneous
Site of Care:
Outpatient
Website:
Approved Indication:
- maintenance treatment of moderaly to severely active ulcerative colitis in adults following treatment with an infliximab product administered intravenously
- maintenance treatment of moderately-to-severely active Crohn’s disease in adults following treatment with an infliximab product administered intravenously>
Conditions:
- Crohn’s Disease
- Ulcerative Colitis
Therapeutic Area:
- Gastroenterology